Margin Breakdown
| Pretax Profit Margin | (13.74) | |
| Operating Profit Margin | (15.48) | |
| Net Profit Margin | (13.74) | |
| Gross Profit Margin | 0.5 |
Our latest forecast of Immutep (USA Stocks:IMMP)
 | By Vlad Skutelnik | Macroaxis Story |
Immutep Ltd ADR stock, currently priced at $3.48 per share, is undervalued based on conservative future projections. Approximately 2.0% of Immutep's shares are held by institutional investors. Insider ownership in Immutep Ltd ADR refers to the equity held by the company's officers, directors, leadership team relatives, or anyone with access to non-public information. For a comprehensive analysis of Immutep, including its current ownership structure, refer to our latest ownership diagnostics.
Primary Takeaways
Despite Immutep Ltd ADR Stock (IMMP) experiencing a maximum drawdown of 41.27% and a negative total risk alpha of -0.51, its recent price action indicator of 0.04 and a day typical price of $2.16 suggest potential for recovery. Given the biotechnology industry's inherent volatility, investors should consider IMMP as a high-risk, high-reward play for August 2024.Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Raphi Shpitalnik
Every cloud has a silver lining, and in the world of biotechnology stocks, Immutep Ltd ADR (IMMP) could be that glimmer of hope for investors seeking a recovery play in August 2024. As a key player in the healthcare sector, Immutep has had its fair share of ups and downs, with a 52-week high of $3.34 and a low of $1.58.
Despite the volatility, Wall Street analysts have a strong buy consensus on the stock, with three strong buys and one buy. They have set a target price of $8.01, indicating a potential upside from the current 50-day moving average of $2.48. This optimism is further supported by the company's accumulation distribution figure of 0.0275, suggesting that the stock is being accumulated more than it's being distributed.
However, it's worth noting that Immutep has a high beta of 1.901, indicating a higher level of risk and potential for higher returns. Additionally, the company has a significant short interest, with 5.3 million shares short as of the previous month, representing a short ratio of 12.38. This could lead to a potential short squeeze, further driving up the stock price if the company posts positive news or results.
In conclusion, while Immutep carries certain risks, its strong buy consensus among analysts and potential for a short squeeze make it an attractive recovery play for August 2024. As always, investors should conduct their own due diligence before making investment decisions. Currently, Immutep's Shareholders Equity Per Share remains relatively stable compared to the previous year. As of 07/28/2024, Average Receivables are expected to increase to approximately 4.1M, while Free Cash Flow Yield is likely to decrease by 0.01. This article aims to analyze Immutep's potential for August, focusing on whether the stock is reasonably priced for the upcoming month.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as Immutep Ltd ADR. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Predictive Modules for Immutep
How important is Immutep's Liquidity
Immutep financial leverage refers to using borrowed capital as a funding source to finance Immutep Ltd ADR ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Immutep financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Immutep's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Immutep's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Immutep's total debt and its cash.
Immutep Gross Profit
Immutep Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Immutep previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Immutep Gross Profit growth over the last 10 years. Please check Immutep's gross profit and other fundamental indicators for more details.
Breaking it down
Immutep price fall over the last few months may raise some interest from retail investors. The stock closed today at a share price of 2.17 on very low momentum in trading volume. The company directors and management were not very successful in positioning the firm resources to exploit market volatility in June. However, diversifying your holdings with Immutep Ltd ADR or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.25.The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Immutep Ltd ADR partners.
Every cloud has a silver lining, and Immutep Ltd ADR Stock (IMMP) could be the ray of hope for investors looking for a recovery play in August 2024. Despite a 52-week low of $1.58, the stock has a Wall Street target price of $8.01, indicating a potential upside of 7.49. The company's strong financial health, reflected in a current ratio of 14.16X and minimal total debt of $1.23M, make it an attractive investment. However, investors should be aware of the company's high probability of bankruptcy at 49.10% and its negative return on equity at -0.42. Despite these risks, IMMP's strong working capital of $125.19M and cash equivalents of $80M provide a safety cushion, making it a potential recovery play for the savvy investor..
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Immutep Ltd ADR. Please refer to our Terms of Use for any information regarding our disclosure principles.